Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65576 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-FLUORO-2-(PIPERIDIN-4-YLOXY)PYRIDINE HCL
CAS :Degré de pureté :95.0%Masse moléculaire :232.67999267578125R-(-)-N-Demethyl Deprenyl-d5
CAS :Produit contrôlé<p>Applications A labelled metabolite of Deprenyl (D288641) (Selegiline).<br>References Dyck, L., et al.: Drug Metab. Dispos., 29, 1156 (2001), Damaj, M., et al.: J. Pharmacol. Exp. Ther., 320, 250 (2007),<br></p>Formule :C12H10D5NCouleur et forme :NeatMasse moléculaire :178.292-((7-Bromo-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)isoindoline-1,3-dione
CAS :Degré de pureté :98%Masse moléculaire :384.18899536132814-[6-(2-Methoxy-phenyl)-pyridin-3-yl]-pyrimidin-2-ylamine
Degré de pureté :95.0%Masse moléculaire :278.31500244140625Descyano Cimetidine Dihydrochloride Salt
CAS :<p>Impurity Cimetidine EP Impurity D<br>Stability Hygroscopic<br>Applications Descyano Cimetidine Dihydrochloride Salt (Cimetidine EP Impurity D) is a metabolite of Cimetidine (C441650); a competitive histamine H2-receptor antagonist which inhibits gastric acid secretion and reduces pepsin output.<br>References Brimblecombe, R.W., et al.: J. Int. Med. Res., 3, 86 (1975); Durant, G.J., et al.: J. Med. Chem., 20, 901 (1977)<br></p>Formule :C9H17N5S·2ClHCouleur et forme :NeatMasse moléculaire :300.25Bufuralol-d9 Hydrochloride
CAS :Produit contrôlé<p>Applications A β-Adrenergic blocker with peripheral vasodilating activity. Antianginal; antihypertensive.<br>References Francis, R.J., et al.: Eur. J. Clin. Pharmacol., 23, 529 (1982), Pfisterer, M., et al.: J. Cardiovasc. Pharmacol., 6, 417 (1984), Narimatsu, S., et al.: J. Pharmacol. Exp. Ther., 303, 172 (2002), Flanagan, J., et al.: Biochem. J., 380, 353 (2004),<br></p>Formule :C16H15D9ClNO2Couleur et forme :NeatMasse moléculaire :306.88N-(5-IODO-PYRIDIN-2-YL)-4-METHYL-BENZENESULFONAMIDE
CAS :Degré de pureté :95.0%Masse moléculaire :374.200012207031252,4,6-Tris(3,5-dimethyl-1H-pyrazol-1-yl)-1,3,5-triazine
CAS :Degré de pureté :98%Masse moléculaire :363.42898559570312-(4-morpholinyl)propanohydrazide dihydrochloride
CAS :Degré de pureté :95.0%Masse moléculaire :246.13000488281256-FLUORO-3-METHYL-2-PHENYLQUINOLINE-4-CARBOXYLIC ACID
CAS :Degré de pureté :95.0%Masse moléculaire :281.28601074218752-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide
CAS :Produit contrôlé<p>Impurity Leflunomide EP Impurity H<br>Stability Hygroscopic<br>Applications 2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide (Leflunomide EP Impurity H) is used to prepare aminothiophene carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers. It is also used to synthesize (1,2,3-triazol-4-yl)benzenamines as inhibitors against VEGF receptors 1 and 2.<br>References Nikolakopoulos, G., et al.: Bioorg. Med. Chem., 14, 2358 (2006); Kiselyov, A., et al.: Bioorg. Med. Chem. Lett., 19, 1344 (2009)<br></p>Formule :C10H7F3N2OCouleur et forme :NeatMasse moléculaire :228.174-Fluoro-3-(((5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)methyl)amino)-N-(3-(trifluoromethoxy)phenyl)benzamide
CAS :Degré de pureté :97.0%Masse moléculaire :485.44299316406252-Pyridin-2-yl-benzooxazol-5-ylamine
CAS :Couleur et forme :SolidMasse moléculaire :211.2239990234375Raltegravir-d3 b-D-Glucuronide (>90%)
CAS :Produit contrôlé<p>Applications A labelled metabolite of Raltegravir.<br>References Bosma, P., et al.: J. Biol. Chem., 269, 17960 (1994) , Richman, D., et al.: Nature, 410, 995 (2001), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Miners, J., et al.: Biochem. Pharmacol., 71, 1531 (2006),<br></p>Formule :C26H26D3FN6O11Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :623.562-(2,5-dimethyl-1H-indol-3-yl)-N-(thiophen-2-ylmethyl)ethan-1-amine hydrochloride
CAS :Degré de pureté :95.0%Masse moléculaire :320.8800048828125N-Methyl-O-(10H-phenothiazine-10-carbonyl)hydroxylamine hydrochloride
CAS :Degré de pureté :95%Masse moléculaire :308.77999877929691-(1-Propyl-1H-pyrazol-4-yl)ethylamine
CAS :Formule :C8H15N3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :153.2295-Amino-1-cyclopropyl-6,7-difluoro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS :Degré de pureté :95+%Masse moléculaire :294.257995605468755-METHYL-3-(3-NITROPYRIDIN-4-YL)CYCLOHEX-2-ENONE
CAS :Degré de pureté :95.0%Masse moléculaire :232.238998413085948-ethyl-4-(thiophene-2-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :324.39999389648444-(2-Aminoanilino)pyridine
CAS :Produit contrôlé<p>Applications An intermediate used to prepare Timiperone as well as cyclooxygenase-2 inhibitors and adrenergic agents<br>References Eftink, M.R., et al.: J. Phys. Chem., 99, 5713 (1995), Palmer, B.D., et al.: J. Med. Chem., 41, 5457 (1998), Pinto, I., et al.: J. Med. Chem., 51, 7205 (2008),<br></p>Formule :C11H11N3Couleur et forme :NeatMasse moléculaire :185.23Gabapentin Related Compound A
CAS :Produit contrôlé<p>Impurity Gabapentin EP Impurity A; Gabapentin USP Related Compound A<br>Applications Gabapentin Lactam (Gabapentin EP Impurity A; Gabapentin USP Related Compound A) reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington’s disease. It opens mitochondrial ATP-dependent potassium channels.<br>References Zucker, B.,et al.: Naunyn Schmiedebergs Arch. Pharmacol., 370, 131 (2004)<br></p>Formule :C9H15NOCouleur et forme :WhiteMasse moléculaire :153.225-(CHLOROMETHYL)-3-(3-PHENOXYPYRIDIN-4-YL)-1,2,4-OXADIAZOLE
Degré de pureté :95.0%Masse moléculaire :287.70001220703125Ethyl 1,5-diphenyl-1H-pyrazole-3-carboxylate
CAS :Degré de pureté :95.0%Masse moléculaire :292.33801269531254”-trans-Hydroxy Cilostazol
CAS :Produit contrôlé<p>Applications A metabolite of Cilostazol.<br>References de Morais, S., et al.: J. Biol. Chem., 269, 15419 (1994), Tata, P; J Pharm Biomed Anal 2001, 24, 381 ,Hiratsuka, M; Eur J Clin Pharmacol 2002, 58, 417 ,,Roy, J; Drug Metab Dispos 2005, 33, 884<br></p>Formule :C20H27N5O3Couleur et forme :NeatMasse moléculaire :385.46Reduced Haloperidol-d4
CAS :Produit contrôlé<p>Applications Labelled Haloperidol Metabolite II<br>References Cutroneo, P., et al.: J. Pharm. Biomed. Anal., 41, 333 (2006), Sheridan, R., et al.: J. Med. Chem., 50, 3173 (2007), Lee, I., et al.: Eur. J. Pharmacol., 578(2, 123 (2008), Entrena, J., et al.: Psychopharmacol., 205, 21 (2009),<br></p>Formule :C21H21D4ClFNO2Couleur et forme :White To Light YellowMasse moléculaire :381.9N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
CAS :Degré de pureté :95.0%Masse moléculaire :396.6700134277344Mirabegron O-Glucuronide Sodium Salt
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications Mirabegron O-Glucuronide Sodium Salt is the is related to the compound Mirabegron O-Glucuronide (M364905) whcich is a metabolite of Mirabegron (M364900).<br>References van Teijilingen, R., et al.: J. Chromat. B., 887, 102 (2012)<br></p>Formule :C27H31N4O8S·xNaCouleur et forme :NeatMasse moléculaire :572.631-Phenyl-2-pyrazin-2-yl ethanol
CAS :Formule :C12H12N2ODegré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :200.241Ritonavir-13C3
CAS :Produit contrôlé<p>Applications A stable labelled selective HIV protease inhibitor Ritonavir (R535000). It is a COVID19-related research product.<br>References Daluge, S., et al.: Antimicrob. Agents Chemother., 38, 1590 (1994), Ammaranond, P., et al.: J. Clin. Virol., 26, 153(2003), Harrigan, P., et al.: J. Infect. Dis., 191, 339 (2005), Miller, J., et al.: Bioorg. Med. Chem. Lett., 16, 1788 (2006)<br></p>Formule :C3C34H48N6O5S2Couleur et forme :NeatMasse moléculaire :723.926-chloro-2-(2-methylphenyl)quinoline-4-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :297.7399902343753-acetyl-6-chloro-4-(4-methoxyphenyl)quinolin-2(1H)-one
CAS :Degré de pureté :95.0%Masse moléculaire :327.7600097656254-METHYL-6-NITRO-2-(PYRROLIDIN-1-YL)QUINOLINE
CAS :Degré de pureté :95.0%Masse moléculaire :257.29299926757815-Acetyl-2-(2,4-di-tert-butylphenoxy) pyridine
CAS :Degré de pureté :95%Masse moléculaire :325.4519958496094N-Desmethyl Regorafenib (Pyridine)-N-oxide
CAS :Produit contrôlé<p>Stability Light Sensitive<br>Applications N-Desmethyl Regorafenib (Pyridine)-N-oxide is a synthetic metabolite of Regorafenib (R143000) and is used for treatment and prevention of cancer.<br>References Wilhelm, S.: PCT Int. Appl. WO 2011130728 A1 20111020. Oct 20, 2011<br></p>Formule :C20H13ClF4N4O4Couleur et forme :NeatMasse moléculaire :484.798-methyl-4-(pyridine-3-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :305.3340148925781(S)-2-(((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)(nitroso)amino)-3-methylbutanoic Acid
CAS :Produit contrôléFormule :C19H20N6O3Couleur et forme :Light YellowMasse moléculaire :380.46-CHLORO-2-(TRIFLUOROMETHOXY)NICOTINIC ACID
CAS :Formule :C7H3ClF3NO3Degré de pureté :98%Masse moléculaire :241.551-(5-NITROPYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE
CAS :Degré de pureté :97.0%Masse moléculaire :240.2220001220703N-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)-6-nitroquinazolin-4-amine
CAS :Degré de pureté :95.0%Masse moléculaire :461.88000488281253,6-Diiodo-1H-indazole
CAS :Produit contrôlé<p>Applications 3,6-Diiodo-1H-indazole is used to prepare aryl-substituted indazole derivatives as modulators and inhibitors of protein kinases in the treatment of tumor growth, cellular proliferation, and angiogenesis.<br>References Kania, R., et al.: PCT Int. Appl., WO 2001002369 A2 20010111 (2001)<br></p>Formule :C7H4I2N2Couleur et forme :NeatMasse moléculaire :369.934-(4-ETHYNYLPHENYL)MORPHOLINE
CAS :Degré de pureté :95.0%Couleur et forme :Liquid, No data available.Masse moléculaire :187.242004394531251-Phenyl-3-thiophen-2-yl-1H-pyrazole-5-carboxylic acid
CAS :Couleur et forme :SolidMasse moléculaire :270.309997558593754-(Piperazin-1-yl)quinazoline dihydrochloride
CAS :Degré de pureté :98.0%Masse moléculaire :287.190002441406253-Pyridin-4-yl-quinoxaline-2-carboxylic acid
Degré de pureté :95.0%Masse moléculaire :251.24499511718753-cyclopropyl-1-(4-fluorophenyl)-1H-pyrazol-5-amine
CAS :Degré de pureté :95+%Masse moléculaire :217.2469940185547(4-Amino-6-methylpyridin-3-yl)methanol
CAS :Degré de pureté :95.0%Masse moléculaire :138.16999816894536-chloro-2-(2-thienyl)quinoline-4-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :289.73001098632816-ethyl-N-(pyridin-2-ylmethyl)-1,3-benzothiazol-2-amine
CAS :Degré de pureté :95.0%Masse moléculaire :269.36999511718753-Phenyl-1-p-tolyl-1H-pyrazol-5-ylamine
CAS :Degré de pureté :95.0%Masse moléculaire :249.31700134277344Diphenylglycoluril
CAS :Produit contrôlé<p>Applications Diphenylglycoluril is a bicyclic bis-urea derivative. Studies suggest that it has potential anticonvulsant activity.Diphenylglycoluril is also an impurity found in the synthesis of Phenytoin (D491650).<br>References Khlebnikov, A.I. et al.: Pharm. Chem. J., 36, 240 (2002); Babkibayev, A.A. et al.: Pharm. Chem. J., 8, 15 (1994);<br></p>Formule :C16H14N4O2Couleur et forme :NeatMasse moléculaire :294.31Tranilast
CAS :Produit contrôlé<p>Applications Antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.<br>References Shiota, N., et al.: Brit. J. Pharmacol., 159, 626 (2010), Gohil, V., et al.: Nat. Biotechnol., 28, 249 (2010), Kawabata, Y., et al.: Eur. J. Pharm. Sci., 39, 256 (2010),<br></p>Formule :C18H17NO5Couleur et forme :NeatMasse moléculaire :327.336-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine
CAS :Degré de pureté :97.0%Masse moléculaire :221.649993896484382-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications 2-[2-[[4-[(5S)-5-[[[(5-chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride is a metabolite of Rivaroxaban (R538000) which is a novel antithrombotic agent. Rivaroxaban is also a highly potent and selective, direct FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005)<br></p>Formule :C19H20ClN3O6S·HClCouleur et forme :White Light RedMasse moléculaire :453.9036462,6-Diaminoisonicotinic acid
CAS :Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :153.14100646972656Desisopropyl Atrazine
CAS :Produit contrôlé<p>Applications A metabolite of Atrazine (ATR) (A794600).<br>References Compton, D., et al.: Eur. J. Pharmacol., 110, 157 (1985), Das, P., et al.: Toxicol. Sci., 59, 127 (2001), Das, P., et al.: Life Sci., 73, 3123 (2003), Coban, A., et al.: J. Neurochem., 100, 1177 (2007),<br></p>Formule :C5H8ClN5Couleur et forme :Off-WhiteMasse moléculaire :173.60N”Nitrosoketamine
CAS :Produit contrôléFormule :C13H15ClN2O2Couleur et forme :White To Light YellowMasse moléculaire :266.723Prochlorperazine Sulfoxide-d3
CAS :Produit contrôlé<p>Applications A labelled metabolite of Prochlorperazine.<br>References Finn, A., et al.: J. Clin. Pharmacol., 45, 1383 (2005),<br></p>Formule :C202H3H21ClN3OSCouleur et forme :Off WhiteMasse moléculaire :392.96(Z)-1,2-Diphenyl-1-(4-hydroxyphenyl)-1-butene (contain up to 10% E-isomer)
CAS :Produit contrôléFormule :C22H20OCouleur et forme :NeatMasse moléculaire :300.394Gleevec-d8 Mesylate (Imatinib-d8 Mesylate)
CAS :Produit contrôlé<p>Applications A deuterated tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). It is a COVID19-related research product.<br>References Schindler, T., et al.: Science, 289, 1938 (2000), Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2001),<br></p>Formule :C292H8H23N7O·CH4O3SCouleur et forme :NeatMasse moléculaire :597.76Tetramethylurea
CAS :<p>Applications Tetramethylurea is an excellent solvent for organic substances, in particular aromatic compounds.<br>References Lüttringhaus, A., et al.: Angew. Chem. Int. Ed. Engl., 3, 260 (1964)<br></p>Formule :C5H12N2OCouleur et forme :NeatMasse moléculaire :116.16rac-erythro Methylphenidate Hydrochloride
CAS :Produit contrôlé<p>Applications The erythro isomers have been shown to exhibit very little therapeutic effect and contribute mainly to the toxic hypertensive effects of this drug.Controlled substance.<br>References Greenblatt, E.N., et al.: J. Pharmacol. Exp. Ther., 131, 115 (1961), Padmanabhan, G.R., et al.: Anal. Profiles Drug Subs., 10, 473 (1981), Kuczenski, R., et al.: J. Pharmacol. Exp. Ther., 296, 876 (2001), Pelham, W.E., et al.: J. Consult. Clin. Psychol., 61, 506 (1993), Srinivas, N.R., et al.: Pharm. Res., 10, 14 (1993),<br></p>Formule :C14H19NO2·ClHCouleur et forme :NeatMasse moléculaire :269.77Adrafinil
CAS :Produit contrôléFormule :C15H15NO3SCouleur et forme :Off-White Light Orange ColourMasse moléculaire :289.351-(2,3-Dimethylphenyl)ethyl Chloride
CAS :Produit contrôlé<p>Applications 1-(2,3-Dimethylphenyl)ethyl Chloride is an impurity of Medetomidine (M203250), an α2-Adrenergic agonist. Sedative; analgesic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Scheinin, M., et al.: Br. J. Clin. Pharmacol., 24, 443 (1987), Stenberg, D., et al.: J. Vet. Pharmacol. Ther., 10, 319 (1987), Virtanen, R., et al.: Eur. J. Pharmacol., 150, 9 (1988), Cullen, L.K., et al.: Br. Vet. J., 152, 519 (1996),<br></p>Formule :C10H13ClCouleur et forme :Clear Colourless To Dark BrownMasse moléculaire :168.66rac Kynurenine
CAS :Produit contrôlé<p>Applications A tryptophan metabolite, is a precursor of kynurenic acid, which is an antagonist of N-methyl-aspartate receptor. An amino acid produced in the body from tryptophan.<br>References Swartz, K., et al.: J. Neurosci., 10, 2965 (1990), Hasegawa, H., et al.: Anal. Bioanal. Chem., 377, 886 (2003), Tsai, Y., et al.: Anal. Biochem., 319, 34 (2003), Mitsuhashi, S., et al.: Anal. Chim. Acta, 584, 315 (2007),<br></p>Formule :C10H12N2O3Couleur et forme :NeatMasse moléculaire :208.21(R)-2-Bromo Phenylephrine Hydrochloride
CAS :Produit contrôlé<p>Applications (R)-2-Bromophenylephrine is the R-2-brominated analogue of the α-adrenergic agonist, Phenylephrine (P320640).<br></p>Formule :C9H13BrClNO2Couleur et forme :NeatMasse moléculaire :282.563-Hydroxy-4-morpholino-1,2,5-thiazole
CAS :<p>Impurity Timolol EP Impurity D; Timolol BP Impurity D; Timolol USP Related Compound D<br>Applications 3-Hydroxy-4-morpholino-1,2,5-thiazole (Timolol EP Impurity D; Timolol BP Impurity D; Timolol USP Related Compound D) is an intermediate for the preparation of Timolol.<br>References Bodor, N., et al.: J. Med. Chem., 31, 100 (1988),<br></p>Formule :C6H9N3O2SCouleur et forme :White To Off-WhiteMasse moléculaire :187.225-(4-Chloro-pyrazol-1-ylmethyl)-furan-2-carboxylic acid
CAS :Formule :C9H7ClN2O3Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :226.62N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine Methyl Ester Hydrochloride
CAS :Produit contrôlé<p>Applications Hydrochloride Salt of N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine Methyl Ester is an intermediate in the preparation of angiotensin II type 1 receptor antagonists.<br>References Goossen, L.J. et al.: J. Org. Chem., 72, 7473 (2007); Nie, Y. et al.: Bioorg. Med. Chem., 20, 2747 (2012);<br></p>Formule :C20H22N2O2·ClHCouleur et forme :NeatMasse moléculaire :358.86Etomidate
CAS :Produit contrôlé<p>Applications Etomidate is a hypnotic. Neuroprotective & Neuroresearch Products<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Goetz, E., et al.: Anaesthesist, 23, 331 (1974), Chang, Z. L., et al.: Anal. Profiles Drug Subs., 12, 191 (1983),<br></p>Formule :C14H16N2O2Couleur et forme :Off-WhiteMasse moléculaire :244.292-(1H-1,2,3-Benzotriazol-1-yl)quinoline
CAS :Degré de pureté :98.0%Masse moléculaire :246.27299499511725-Hydroxy Dantrolene-d4
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications A labelled metabolite of Dantrolene (D185000) that has shown to have muscle relaxant effects.<br>References Ellis, K.O., et al.: J. Med. Chem., 21, 127 (1977), Jayyosi, Z., et al.: Drug Metab. Dispos., 21, 939 (1993),<br></p>Formule :C14H6D4N4O6Couleur et forme :NeatMasse moléculaire :334.28(3,3′-Difluoro-[2,2′-bithiophene]-5,5′-diyl)bis(trimethylstannane)
CAS :Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :527.84997563-Methyl-6-nitro-quinoxaline-2-carboxylic acid benzyl ester
Degré de pureté :95.0%Masse moléculaire :323.30801391601568-methyl-2-(5-methyl-2-furyl)quinoline-4-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :267.283996582031251,2,3,4-Tetrahydro-4,8-dihydroxy-2-methyl-isoquinoline
CAS :<p>Impurity Phenylephrine 4,6-DMTQ Impurity (Peak-2)<br>Applications Product formed during the decomposition of Phenylephrine<br>References Millard, B., et al.: J. Pharm. Pharmacol., 25, 24 (1973),<br></p>Formule :C10H13NO2Couleur et forme :Light YellowMasse moléculaire :215.686,7-DIMETHOXY-2-METHYL-4-(PIPERAZIN-1-YL)QUINAZOLINE
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :288.351013183593755-(1,3-Dioxolan-2-yl)-2-(4-phenoxybenzoyl)thiophene
CAS :Degré de pureté :97.0%Masse moléculaire :352.39999389648444-Isopropoxy-N-(2-methylquinolin-8-yl)benzamide
CAS :Degré de pureté :97.0%Masse moléculaire :320.3919982910156(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide
CAS :<p>Impurity Levetiracetam USP Related Compound A<br>Applications (S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide is a related compound of Levetiracetam (L331500). Levetiracetam related compound A. Levetiracetam USP Related Compound A.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Formule :C8H15ClN2O2Couleur et forme :White To Off-WhiteMasse moléculaire :206.676-chloro-2-pyridin-4-ylquinoline-4-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :284.70001220703125Famotidine Amide Impurity Hydrochloride
CAS :<p>Applications Famotidine impurity.<br>References Junnarkar, G., et al.: Pharm. Res., 12, 599 (1995), Singh, S., et al.: J. Pharm. Sci., 91, 253 (2002),<br></p>Formule :C8H14ClN5OS2Couleur et forme :White SolidMasse moléculaire :295.81Tulobuterol-d9 Hydrochloride
CAS :Produit contrôlé<p>Applications Labelled Tulobuterol (T897250). A sympathomimetic drug used as a transdermal patch, increases normal diaphragm muscle strength. A β-adrenergic receptor agonist, related structurally to Terbutaline (T109750).<br>References Kubo, S., et al.: Arzneim.-Forsch., 25, 1028 (1975), Uematsu, T., et al.: Eur. J. Clin. Pharmacol., 44, 361 (1993), Qureshi, S., et al.: J. Exp. Med., 189, 615 (1999),<br></p>Formule :C122H9H9ClNO·ClHCouleur et forme :White To Off WhiteMasse moléculaire :273.254-(4-oxoquinazolin-3(4H)-yl)benzoic acid
CAS :Degré de pureté :95.0%Masse moléculaire :266.256011962891
![4-[6-(2-Methoxy-phenyl)-pyridin-3-yl]-pyrimidin-2-ylamine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF511273.webp&w=3840&q=75)
![2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC982245.webp&w=3840&q=75)
![8-ethyl-4-(thiophene-2-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF525675.webp&w=3840&q=75)
![8-methyl-4-(pyridine-3-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF525651.webp&w=3840&q=75)
![(S)-2-(((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)(nitroso)amino)-3-methylbutanoic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT310923.webp&w=3840&q=75)
![1-(5-NITROPYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF471341.webp&w=3840&q=75)
![2-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]e…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC421840.webp&w=3840&q=75)
![N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine Methyl Ester Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC962340.webp&w=3840&q=75)
![(3,3′-Difluoro-[2,2′-bithiophene]-5,5′-diyl)bis(trimethylstannane)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF634176.webp&w=3840&q=75)
